Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Author(s) -
Kelly Metcalfe,
Henry T. Lynch,
Parviz Ghadirian,
Nadine Tung,
Ivo A. Olivotto,
Ellen Warner,
Olufunmilayo I. Olopade,
Andrea Eisen,
Barbara Weber,
Jane McLennan,
Ping Sun,
William D. Foulkes,
Steven A. Narod
Publication year - 2004
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2004.04.033
Subject(s) - medicine , breast cancer , cancer , oncology , mutation , gynecology , cancer research , genetics , gene , biology
To estimate the risk of contralateral breast cancer in BRCA1 and BRCA2 carriers after diagnosis and to determine which factors are predictive of the risk of a second primary breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom